Qube Research & Technologies LTD Spero Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.2 - $1.63 $1 - $1	1 New	1 $0
Q3 2022 Nov 14, 2022	SELL	$0.68 - $2.2 $1,166 - $3,775	-1,716 Reduced 9.71%	15,948 $32,000
Q2 2022 Aug 15, 2022	BUY	$0.74 - $7.44 $13,071 - $131,420	17,664 New	17,664 $13,000
Q2 2021 Aug 13, 2021	SELL	$12.22 - $15.79 $304,009 - $392,823	-24,878 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.23 - $21.48 $329,135 - $534,379	24,878 New	24,878 $366,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.